New Key Statistics Module, Z-Score and F-Score
NAS:ENTA Key Ratios
| Market Cap $ M | 279.89 |
| Enterprise Value $ M | -15.48 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.46 |
| Price/Sales | 3.87 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 73.00 |
| EPS (TTM) $ | -6.56 |
| Beneish M-Score | -3.79 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.12 |
| EV-to-EBITDA | 0.12 |
| PEG | -- |
| Shares Outstanding M | 21.16 |
| Net Margin (%) | -187.77 |
| Operating Margin % | -192.99 |
| Pre-tax Margin (%) | -184.73 |
| Quick Ratio | 6.25 |
| Current Ratio | 6.25 |
| ROA % (ttm) | -33.55 |
| ROE % (ttm) | -56.81 |
| ROIC % (ttm) | -160.12 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.07 |
| Piotroski F-Score | 3.00 |
| Positive ROA | N |
| Positive CFROA | N |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | Y |
ENTA Number of Guru Trades
ENTA Volume of Guru Trades
Gurus Latest Trades with NAS:ENTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ENTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Enanta Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ENTA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers